NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits have been initiated on behalf of Barclays PLC shareholders UCSWarner Bros. Discovery, Inc. WBDOlo, Inc. OLOand Centessa Pharmaceuticals Plc CNTA. Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

Barclays PLC UCS

Class Period: February 18, 2021 – March 25, 2022

Lead Plaintiff Deadline: November 22, 2022

Barclays is a British universal bank. Its businesses include consumer banking and payments around the world, as well as global corporate and investment banking.

Barclays has announced that as of February 18, 2021, Barclays Bank PLC (“BBPLC”), a wholly owned subsidiary of Barclays, will sell approximately $17.64 billion worth of unregistered securities. Barclays has also admitted that “due to the fact that the overspending took place and was not immediately identified, both [Barclays] and BBPLC had a material weakness related to certain aspects of their internal control environment and, as a result, their internal control over financial reporting was not effective for the year ended December 31, 2021 Year ended December 31, 2021, adjusted. BBPLC has also filed a tender offer for the unregistered securities.

The truth emerged on Monday, March 28, 2022, when Barclays disclosed over-issuance for the first time ahead of the trading market for Barclays ADRs, informing investors that BBPLC had approximately $15.2 billion worth of unregistered securities. spent more than the maximum amount of…